Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Postembolization Syndrome in PAE
NCT04588857Phase 4Unknown
- Sponsor
- Rigshospitalet
- Start
- Mar 2021
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone in post-embolization syndrome (PES), sponsored by Rigshospitalet. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
post-embolization syndrome (PES)
Beyond the preview
Go deeper on NCT04588857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588857.